glp-1 and parkinson's Glucagon-like peptide-1 medicines in neurological psychiatric disorders: Cell Reports Medicine Role of glucagon-like peptide-1 receptor

Medications such as interferon and interleukin-2 (aldesleukin) also can cause type II

After pulling its ALS drug Relyvrio from the market, Amylyx Pharmaceuticals is looking to target the GLP-1 space with the purchase of Eiger BioPharmaceuticals avexitide, which has been studied for the treatment of hyperinsulinemic hypoglycemia

Helps in muscle fullness through higher levels of water retention in the muscle cells

A case study approach is employed, focusing primarily on document analysis of materials related to a visionary rural area development process: the Holwerd aan Zee (Holwerd by the Sea) project, located in the north of the Netherlands